4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001228684-25-000005
Director sold 22,946 shares at an average $81.26 ($1,864,678)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LINK WILLIAM J PHD · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-15 | Sale : show line 1 in the form 10b5-1 | −5,046 | $80.80 | $407,717 | 136,286 | D |
| 2025-12-15 | Sale : show line 2 in the form 10b5-1 | −6,306 | $81.75 | $515,516 | 129,980 | D |
| 2025-12-15 | Sale : show line 3 in the form 10b5-1 | −1,148 | $82.39 | $94,584 | 128,832 | D |
| 2025-12-15 | Sale : show line 4 in the form 10b5-1 | −5,680 | $80.71 | $458,433 | 4,766 | I |
| 2025-12-15 | Sale : show line 5 in the form 10b5-1 | −4,766 | $81.50 | $388,429 | 0 | I |
| Open-market sales · 22,946 sh · avg $81.26 · $1,864,678 | ||||||
Loading xslF345X05/wk-form4_1766005663.xml…